Product References
Identification of human adenovirus replication inhibitors from a library of small molecules targeting cellular epigenetic regulators.
Virology
Saha B,Parks RJ
Published figure using Adenovirus Type 5 monoclonal antibody (Product # MA5-13643) in Western Blot
Mon Mar 01 00:00:00 EST 2021
Cell-to-cell and genome-to-genome variability of adenovirus transcription tuned by the cell cycle.
Journal of cell science
Suomalainen M,Prasad V,Kannan A,Greber UF
MA5-13643 was used in Immunocytochemistry to measure the abundance of viral transcripts using single-molecule RNA fluorescence in situ hybridization (FISH) and the incoming 5-ethynyl-2'-deoxycytidine (EdC)-tagged viral genomes using a copper(I)-catalyzed azide-alkyne cycloaddition (click) reaction.
Mon Nov 09 00:00:00 EST 2020
Antiviral Effects of Curcumin on Adenovirus Replication.
Microorganisms
Jennings MR,Parks RJ
Published figure using Adenovirus Type 5 monoclonal antibody (Product # MA5-13643) in Western Blot
Sun Oct 04 00:00:00 EDT 2020
Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Suppresses Human Adenovirus Gene Expression and Replication.
Journal of virology
Saha B,Parks RJ
Published figure using Adenovirus Type 5 monoclonal antibody (Product # MA5-13643) in Western Blot
Sat Jun 15 00:00:00 EDT 2019
The Efficacy of Oncolytic Adenovirus Is Mediated by T-cell Responses against Virus and Tumor in Syrian Hamster Model.
Clinical cancer research : an official journal of the American Association for Cancer Research
Li X,Wang P,Li H,Du X,Liu M,Huang Q,Wang Y,Wang S
MA5-13643 was used in Immunohistochemistry to demonstrate, using a Syrian hamster tumour model, the significance of T-cell signalling in mediating antitumor immune responses to oncolytic adenovirus therapy.
Sun Jan 01 00:00:00 EST 2017
Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo.
British journal of cancer
Ulasov IV,Sonabend AM,Nandi S,Khramtsov A,Han Y,Lesniak MS
MA5-13643 was used in western blot to study the mechanism by which a combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma
Tue Apr 07 00:00:00 EDT 2009
Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats.
Cancer gene therapy
Sonabend AM,Ulasov IV,Han Y,Rolle CE,Nandi S,Cao D,Tyler MA,Lesniak MS
MA5-13643 was used in immunohistochemistry to study the biodistribution of an oncolytic adenovirus after intracranial injection in Syrian hamsters and cotton rats
Wed Apr 01 00:00:00 EDT 2009
Construction of urothelium-specific recombinant adenovirus and its inhibition in bladder cancer cell.
Urologia internationalis
He XD,Wang ZP,Wei HY,Zhou Q,Wang DG,Tian JQ,Fu SJ,Rodriguez R
MA5-13643 was used in western blot to develop urothelium-specific adenovirus for bladder cancer treatment
Thu Apr 30 00:00:00 EDT 2009
Evaluation of E1A double mutant oncolytic adenovectors in anti-glioma gene therapy.
Journal of medical virology
Ulasov IV,Tyler MA,Rivera AA,Nettlebeck DM,Douglas JT,Lesniak MS
MA5-13643 was used in western blot to study the use of double mutant oncolytic adenovectors in anti-glioma gene therapy
Mon Sep 01 00:00:00 EDT 2008
The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: Arf inactivation and induction of cellular senescence.
Oncogene
Cheng K,Grisendi S,Clohessy JG,Majid S,Bernardi R,Sportoletti P,Pandolfi PP
MA5-13643 was used in western blot to study the oncogenic function of a leukemia-associated cytoplasmic nucleophosmin mutant
Thu Nov 22 00:00:00 EST 2007
Dual promoter-controlled oncolytic adenovirus CG5757 has strong tumor selectivity and significant antitumor efficacy in preclinical models.
Clinical cancer research : an official journal of the American Association for Cancer Research
Li Y,Idamakanti N,Arroyo T,Thorne S,Reid T,Nichols S,VanRoey M,Colbern G,Nguyen N,Tam O,Working P,Yu DC
MA5-13643 was used in western blot to study the antitumor selectivity and therapeutic potential of a dual promoter-controlled oncolytic adenovirus in preclinical models
Thu Dec 15 00:00:00 EST 2005
Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: a pilot phase II clinical trial.
World journal of gastroenterology
Lu W,Zheng S,Li XF,Huang JJ,Zheng X,Li Z
MA5-13643 was used in immunohistochemistry to investigate the anti-tumor efficacy of a recombinant adenovirus H101 in combination with chemotherapy in patients with late stage cancers
Wed Dec 15 00:00:00 EST 2004